Asia’s Pioneer Test Lab in Oxygen Desaturation
Established in 2020, July 31st, Hypoxia Laboratory SZU (HLSZU) is the collaboration between Shenzhen University General Hospital (SUGH) and Bickler Hypoxia Laboratory (named after Dr. Bickler) of the University of San Francisco, California (UCSF No. 5 ranking hospital in the U.S.).
Hypoxia Laboratory SZU
At present, HLSZU is the only standard hypoxia laboratory with test assessment reports well accepted and recognized by health officials worldwide and regulatory bodies including US FDA, CE and NMPA of China.
Shenzhen University General Hospital (SUGH) completed the filing of NMPA Medical Device Clinical Trial Institution (Device Clinical Trial Institution Filing No. 201900064) on April 4th, 2019, and obtained qualification to carry out clinical testing and data analysis of medical devices. Clinical test reports issued are recognized by the Chinese NMPA and can be used as the evaluation basis for the registration and listing of medical devices. The cooperation between Bickler Hypoxia Laboratory of the U.S and Shenzhen University General Hospital (a GCP certified unit with NMPA filing and approval), is a fundamental condition and basis for its clinical test evaluation report to be recognized by the Chinese NMPA.
Prof. Philip E. Bickler
Lab Honarary Director, Medical Technical Consultant
Professor, Department Of Anesthesia And Perioperative Care, Director Of Hypoxia Research Laboratory And Neuroscience Laboratories, Director of Hypoxia Laboratory of the University Of California, San Francisco.
Dr. Jian Lu
Lab Executive Director, Investigator
Chairman of Infectious Disease & Control Centre and GCP Office in SUGH.
Dr. Yu Fei Lu
Executive Deputy Director
Experienced management and researcher in HLSZU.
Mr. Mike Bernstein
Lab Technical Consultant, internationally renowned professional in oximetry.
Prof. Ji Lun Ye
Lab Technical Consultant, experienced in the field of oximetry & Professor of Biomedical Engineering School in Shenzhen University.
